Ryan Zeidan, a Doctor of Philosophy in Chemistry from Caltech and a Bachelor of Science in Chemical Engineering, Chemistry, and Organic Chemistry from the Massachusetts Institute of Technology, has a long and impressive history in the pharmaceutical industry. He has held several management and executive positions with companies such as Millendo Therapeutics, Celgene, and Novartis. During his tenure at Celgene, he served as Executive Director, Global Program Leader, and was responsible for leading the development of several oncology compounds. Before joining Celgene, Ryan worked at Novartis, where he held several positions, including Head Portfolio and Program Management, Senior Development Project Lead, and Project Lead, to name a few. He has also worked as a senior scientist at Calando Pharmaceuticals and as a project leader at The Boston Consulting Group. Ryan is currently the President and Chief Executive Officer at a yet-to-be-named organization.